Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-09
DOI
10.1038/s41419-018-1274-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes
- (2017) Prasad L. Gawade et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
- (2017) Michiru Nishita et al. Scientific Reports
- Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression
- (2016) Vince Kornél Grolmusz et al. BMC GENOMICS
- TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
- (2016) Liacine Bouaoun et al. HUMAN MUTATION
- A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
- (2016) Brian Leyland-Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis
- (2016) Michael I. Carr et al. Cell Reports
- Experimental and investigational therapies for chemotherapy-induced anemia
- (2015) Ugo Testa et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Regulation of MDM2 Stability After DNA Damage
- (2015) Jiaqi Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- IL-17 induces radiation resistance of B lymphoma cells by suppressing p53 expression and thereby inhibiting irradiation-triggered apoptosis
- (2014) Qingshan Li et al. Cellular & Molecular Immunology
- Erythropoietin Activates Cell Survival Pathways in Breast Cancer Stem-like Cells to Protect Them from Chemotherapy
- (2013) M. Todaro et al. CANCER RESEARCH
- Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells
- (2012) Chi Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer
- (2012) M Aapro et al. BRITISH JOURNAL OF CANCER
- p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
- (2012) James G. Jackson et al. CANCER CELL
- Erythropoietin: The swinging pendulum
- (2012) Howard S. Oster et al. LEUKEMIA RESEARCH
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- Delving deeper: MCL-1's contributions to normal and cancer biology
- (2012) Rhonda M. Perciavalle et al. TRENDS IN CELL BIOLOGY
- Erythropoietin, erythropoiesis and beyond
- (2011) S. Chateauvieux et al. BIOCHEMICAL PHARMACOLOGY
- Analysis of microRNA expression profiles during the cell cycle in synchronized HeLa cells
- (2011) Jue-Yu Zhou et al. BMB Reports
- The phenotype of MDM2 auto-degradation after DNA damage is due to epitope masking by phosphorylation
- (2011) Qian Cheng et al. CELL CYCLE
- Deep Sequencing Reveals Novel MicroRNAs and Regulation of MicroRNA Expression during Cell Senescence
- (2011) Joseph M. Dhahbi et al. PLoS One
- Erythropoietin: back to basics
- (2010) W. Jelkmann BLOOD
- Senescent cells as a source of inflammatory factors for tumor progression
- (2010) Albert R. Davalos et al. CANCER AND METASTASIS REVIEWS
- Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation
- (2010) Ke Liang et al. CANCER CELL
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
- (2010) Maite Huarte et al. CELL
- Therapy-Induced Senescence in Cancer
- (2010) Jonathan A. Ewald et al. JNCI-Journal of the National Cancer Institute
- Erythropoietin: not just about erythropoiesis
- (2010) Pietro Ghezzi et al. LANCET
- Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis
- (2009) M. Tonelli et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Modes of p53 Regulation
- (2009) Jan-Philipp Kruse et al. CELL
- The miR-34 family in cancer and apoptosis
- (2009) H Hermeking CELL DEATH AND DIFFERENTIATION
- Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
- (2009) Julia Bohlius et al. LANCET
- Erythropoietin protects PC12 cells from β-amyloid25–35-induced apoptosis via PI3K/Akt signaling pathway
- (2009) Rong Ma et al. NEUROPHARMACOLOGY
- Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells
- (2008) Randolph M. Abutin et al. EXPERIMENTAL HEMATOLOGY
- Mechanisms of regulatory diversity within the p53 transcriptional network
- (2008) J M Espinosa ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now